Literature DB >> 22535432

Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy.

Changsheng Ma1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22535432     DOI: 10.1160/TH11-04-0214

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  11 in total

1.  "East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.

Authors:  Young-Hoon Jeong
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

Review 2.  Endovascular versus Non-Interventional Therapy for Cervicocranial Artery Dissection in East Asian and Non-East Asian Patients: a Systematic Review and Meta-analysis.

Authors:  Rongzhong Huang; Lingchuan Niu; Ying Wang; Gongwei Jia; Lang Jia; Yule Wang; Wei Jiang; Yang Sun; Lehua Yu
Journal:  Sci Rep       Date:  2015-05-20       Impact factor: 4.379

3.  Total knee Arthroplasty: risk factors for allogeneic blood transfusions in the South Asian population.

Authors:  Syed Hamza Mufarrih; Nada Qaisar Qureshi; Arif Ali; Azeem Tariq Malik; Huda Naim; Shahryar Noordin
Journal:  BMC Musculoskelet Disord       Date:  2017-08-23       Impact factor: 2.362

Review 4.  Ethnic Differences in Oral Antithrombotic Therapy.

Authors:  Haechan Cho; Jeehoon Kang; Hyo Soo Kim; Kyung Woo Park
Journal:  Korean Circ J       Date:  2020-08       Impact factor: 3.243

5.  Comparison between ticagrelor versus clopidogrel in long term outcomes of Taiwanese diabetic subjects with acute coronary syndrome undergoing successful revascularization: From TSOC ACS-DM registry.

Authors:  Cheng-An Wang; Yi-Chen Hsieh; Chun-Yao Huang; Ju-Chi Liu; Ming-Hsiung Hsieh; Yung-Kuo Lin; Jong-Shiuan Yeh
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

6.  Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the STANDARD study.

Authors:  Hiroshi Inoue; Michiaki Umeyama; Takako Yamada; Hiroyuki Hashimoto; Akira Komoto; Masahiro Yasaka
Journal:  J Arrhythm       Date:  2019-05-09

7.  Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention.

Authors:  Kye Taek Ahn; Seok-Woo Seong; Ung Lim Choi; Seon-Ah Jin; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Myung Ho Jeong; Shung Chull Chae; Young Jo Kim; Chong Jin Kim; Hyo-Soo Kim; Myeong-Chan Cho; Hyeon-Cheol Gwon; Jin-Ok Jeong; In-Whan Seong
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

8.  Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: A retrospective, observational study.

Authors:  I-Chih Chen; Wei-Ting Chang; Po-Chao Hsu; Ya-Lan Yeh; Syuan Zheng; Yuan-Chi Huang; Chih-Hsien Lin; Liang-Miin Tsai; Li-Jen Lin; Ping-Yen Liu; Yen-Wen Liu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

9.  Rationale and design of the Chinese Atrial Fibrillation Registry Study.

Authors:  Xin Du; Changsheng Ma; Jiahui Wu; Songnan Li; Man Ning; Ribo Tang; Xueyuan Guo; Deyong Long; Ronghui Yu; Caihua Sang; Chenxi Jiang; Ting Zhang; Jianhong Pan; Xiaohui Liu; Jianzeng Dong; Gregory Y H Lip
Journal:  BMC Cardiovasc Disord       Date:  2016-06-07       Impact factor: 2.298

10.  Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant).

Authors:  Wen Zheng; Yu-Jiao Zhang; Ran Liu; Xue-Dong Zhao; Hui Ai
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.